Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Usefulness and optimization of mouse models of allergic airway disease.

Literature DB >> 18328889

Usefulness and optimization of mouse models of allergic airway disease.

Fred D Finkelman, Marsha Wills-Karp.

Abstract

Entities: Disease Species

Mesh：

Substances：
Anti-Asthmatic Agents

Year: 2008 PMID： 18328889 PMCID： PMC3848028 DOI： 10.1016/j.jaci.2008.01.008

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

× No keyword cloud information.

35 in total

1. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors: H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal: N Engl J Med Date: 1999-12-23 Impact factor: 91.245

2. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Authors: Sabine-Gisela Plötz; Hans-Uwe Simon; Ulf Darsow; Dagmar Simon; Ekatherina Vassina; Shida Yousefi; Rüdiger Hein; Tim Smith; Heidrun Behrendt; Johannes Ring
Journal: N Engl J Med Date: 2003-12-11 Impact factor: 91.245

3. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model.

Authors: W R Henderson; J Lu; K M Poole; G N Dietsch; E Y Chi
Journal: J Immunol Date: 2000-03-15 Impact factor: 5.422

4. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors: S A Bryan; B J O'Connor; S Matti; M J Leckie; V Kanabar; J Khan; S J Warrington; L Renzetti; A Rames; J A Bock; M J Boyce; T T Hansel; S T Holgate; P J Barnes
Journal: Lancet Date: 2000 Dec 23-30 Impact factor: 79.321

5. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

Authors: Jonathan Corren; Thomas Casale; Yamo Deniz; Mark Ashby
Journal: J Allergy Clin Immunol Date: 2003-01 Impact factor: 10.793

Review 6. Interleukin-12: potential role in asthma therapy.

Authors: Patricia Leonard; Sanjiv Sur
Journal: BioDrugs Date: 2003 Impact factor: 5.807

7. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.

Authors: Sally Wenzel; Darren Wilbraham; Rick Fuller; Elise Burmeister Getz; Malinda Longphre
Journal: Lancet Date: 2007-10-20 Impact factor: 79.321

Review 8. Modeling asthma and COPD in animals: a pointless exercise?

Authors: Brendan J Canning
Journal: Curr Opin Pharmacol Date: 2003-06 Impact factor: 5.547

9. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Authors: S H Gavett; D J O'Hearn; X Li; S K Huang; F D Finkelman; M Wills-Karp
Journal: J Exp Med Date: 1995-11-01 Impact factor: 14.307

10. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

Authors: D B Corry; H G Folkesson; M L Warnock; D J Erle; M A Matthay; J P Wiener-Kronish; R M Locksley
Journal: J Exp Med Date: 1996-01-01 Impact factor: 14.307

30 in total

1. Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma model.

Authors: Alexander R Abbas; Janet K Jackman; Sherron L Bullens; Sarah M Davis; David F Choy; Grazyna Fedorowicz; Martha Tan; Bao-Tran Truong; Y Gloria Meng; Lauri Diehl; Lisa A Miller; Edward S Schelegle; Dallas M Hyde; Hilary F Clark; Zora Modrusan; Joseph R Arron; Lawren C Wu
Journal: Am J Pathol Date: 2011-08-03 Impact factor: 4.307

2. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice.

Authors: Jennifer L Ather; Karina Ckless; Rebecca Martin; Kathryn L Foley; Benjamin T Suratt; Jonathan E Boyson; Katherine A Fitzgerald; Richard A Flavell; Stephanie C Eisenbarth; Matthew E Poynter
Journal: J Immunol Date: 2011-05-27 Impact factor: 5.422

Review 3. Importance of cytokines in murine allergic airway disease and human asthma.

Authors: Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal: J Immunol Date: 2010-02-15 Impact factor: 5.422

4. The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases.

Authors: Tamiko R Katsumoto; Makoto Kudo; Chun Chen; Aparna Sundaram; Elliott C Callahan; Jing W Zhu; Joseph Lin; Connor E Rosen; Boryana N Manz; Jae W Lee; Michael A Matthay; Xiaozhu Huang; Dean Sheppard; Arthur Weiss
Journal: J Clin Invest Date: 2013-04-01 Impact factor: 14.808

5. The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22.

Authors: Lauren M Lilly; Melissa A Gessner; Chad W Dunaway; Allison E Metz; Lisa Schwiebert; Casey T Weaver; Gordon D Brown; Chad Steele
Journal: J Immunol Date: 2012-08-29 Impact factor: 5.422

6. Strain-dependent genomic factors affect allergen-induced airway hyperresponsiveness in mice.

Authors: Samir N P Kelada; Mark S Wilson; Urraca Tavarez; Kari Kubalanza; Bhavesh Borate; Greg S Whitehead; Shuichiro Maruoka; Michelle G Roy; Michelle Olive; Danielle E Carpenter; David M Brass; Thomas A Wynn; Donald N Cook; Christopher M Evans; David A Schwartz; Francis S Collins
Journal: Am J Respir Cell Mol Biol Date: 2011-03-04 Impact factor: 6.914

10. Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.

Authors: Aida Herrerias; Rosa Torres; Mariona Serra; Alberto Marco; Laura Pujols; César Picado; Fernando de Mora
Journal: J Inflamm (Lond) Date: 2009-10-30 Impact factor: 4.981